Chari A, Cho HJ, Dhadwal A, et al. A phase 2 study of panobinostat with lenalidomide and weekly dexamethasone in myeloma. Blood Adv. 2017;1(19):1575-1583.

In the last sentence of the abstract on page 1575, the clinical trial number, #NCT00742027, should be #NCT01651039.